Giffoni de Mello Morais Mata, D.; Vargas, T.P.A.; Carmona, C.A.; Al-Humiqani, A.; Gehlaut, S.; Thawer, A.; Romero, M.; Doherty, M.K.; Menjak, I.B.
The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study. Therapeutics 2025, 2, 7.
https://doi.org/10.3390/therapeutics2020007
AMA Style
Giffoni de Mello Morais Mata D, Vargas TPA, Carmona CA, Al-Humiqani A, Gehlaut S, Thawer A, Romero M, Doherty MK, Menjak IB.
The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study. Therapeutics. 2025; 2(2):7.
https://doi.org/10.3390/therapeutics2020007
Chicago/Turabian Style
Giffoni de Mello Morais Mata, Danilo, Tatianny P. Araujo Vargas, Carlos Amir Carmona, Abdullah Al-Humiqani, Sara Gehlaut, Alia Thawer, Maria Romero, Mark K. Doherty, and Ines B. Menjak.
2025. "The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study" Therapeutics 2, no. 2: 7.
https://doi.org/10.3390/therapeutics2020007
APA Style
Giffoni de Mello Morais Mata, D., Vargas, T. P. A., Carmona, C. A., Al-Humiqani, A., Gehlaut, S., Thawer, A., Romero, M., Doherty, M. K., & Menjak, I. B.
(2025). The Impact of Leptomeningeal Metastasis in Patients with Non-Small Cell Lung Cancer with EGFR Mutation: Survival Analysis of a Retrospective Cohort Study. Therapeutics, 2(2), 7.
https://doi.org/10.3390/therapeutics2020007
